Citations (55)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Yusuf Cetin Doganer, Umit Aydogan, Umit Kaplan, Suat Gormel, James Edwin Rohrer & Uygar Cagdas Yuksel. (2023) Statin adherence in patients with high cardiovascular risk: a cross-sectional study. Postgraduate Medicine 135:4, pages 361-369.
Read now
Read now
Valentina Perrone, Elisa Giacomini, Diego Sangiorgi, Margherita Andretta, Fausto Bartolini, Alessandro Lupi, Fulvio Ferrante, Stefano Palcic, Davide Re & Luca Degli Esposti. (2022) Evaluation of the Therapeutic Pattern and Pharmaco-Utilization in Hypercholesterolemic Patients Treated with Statins: A Retrospective Study on Italian Real-World Data. Risk Management and Healthcare Policy 15, pages 1483-1489.
Read now
Read now
Gérard Reach, Laurent Benarbia, Eric Bruckert, Jean-Philippe Kevorkian, Michel Farnier, Jean-Jacques Mourad & Bernard-Charles Vaisse. (2021) Intentionality in adherence to long-term therapies. Results from an online survey of 3,001 patients with cardio-metabolic pathologies in France. Patient Preference and Adherence 15, pages 1739-1753.
Read now
Read now
Michael S. Kostapanos, Moses S. Elisaf & Dimitri P. Mikhailidis. (2012) Targeting cardiovascular risk: the impact of age, gender and compliance to treatment. Current Medical Research and Opinion 28:9, pages 1415-1419.
Read now
Read now
Michael S. Kostapanos, Vasilios G. Athyros, Asterios Karagiannis & Dimitri P. Mikhailidis. (2012) Therapeutic options for statin-intolerant patients. Current Medical Research and Opinion 28:3, pages 345-349.
Read now
Read now
Matilda Florentin, Evangelos N Liberopoulos, Dimitri P Mikhailidis & Moses S Elisaf. (2011) Emerging options in the treatment of dyslipidemias: a bright future?. Expert Opinion on Emerging Drugs 16:2, pages 247-270.
Read now
Read now
Siddhesh A. Kamat, Michael F. Bullano, Chun-Lan Chang, Sanjay K. Gandhi & Mark J. Cziraky. (2011) Adherence to single-pill combination versus multiple-pill combination lipid-modifying therapy among patients with mixed dyslipidemia in a managed care population. Current Medical Research and Opinion 27:5, pages 961-968.
Read now
Read now
Elisavet Moutzouri, Anastazia Kei, Moses S Elisaf & Haralampos J Milionis. (2010) Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid. Vascular Health and Risk Management 6, pages 525-539.
Read now
Read now
Vasilios G Athyros, Konstantinos Tziomalos, Asterios Karagiannis & Dimitri P Mikhailidis. (2010) To switch (statins) or not to switch? That is the question. Expert Opinion on Pharmacotherapy 11:18, pages 2943-2946.
Read now
Read now
Stella S. Daskalopoulou, Robert J. Doonan & Dimitri P. Mikhailidis. (2010) Undertreatment of hypercholesterolemia. Current Medical Research and Opinion 26:2, pages 439-443.
Read now
Read now
Leiv Ose, Dragos Budinski, Neil Hounslow & Valerie Arneson. (2009) Comparison of pitavastatin with simvastatin in primary hypercholesterolaemia or combined dyslipidaemia. Current Medical Research and Opinion 25:11, pages 2755-2764.
Read now
Read now
Dragos Budinski, Valerie Arneson, Neil Hounslow & Nikolai Gratsiansky. (2009) Pitavastatin compared with atorvastatin in primary hypercholesterolemia or combined dyslipidemia. Clinical Lipidology 4:3, pages 291-302.
Read now
Read now
Articles from other publishers (43)
Maria O’Keeffe & Oddrun Anita Gudbrandsen. (2022) Effects of diets containing proteins from fish muscles or fish by-products on the circulating cholesterol concentration in rodents: a systematic review and meta-analysis. British Journal of Nutrition, pages 1-22.
Crossref
Crossref
Kyriakos Souliotis, Theodoros V. Giannouchos, Chistina Golna & Evangelos Liberopoulos. (2021) Assessing forgetfulness and polypharmacy and their impact on health-related quality of life among patients with hypertension and dyslipidemia in Greece during the COVID-19 pandemic. Quality of Life Research 31:1, pages 193-204.
Crossref
Crossref
K. Martin-Latry, P. Latry, Y. Pucheu & T. Couffinhal. (2021) Validation d’une échelle de mesure de l’adhésion médicamenteuse cardiovasculaire utilisable en contexte hospitalier. Annales Pharmaceutiques Françaises 79:4, pages 457-464.
Crossref
Crossref
Eman Alefishat, Anan S. Jarab, Walid Al-Qerem & Lina Abu-Zaytoun. (2021) Factors Associated with Medication Non-Adherence in Patients with Dyslipidemia. Healthcare 9:7, pages 813.
Crossref
Crossref
Ho-Hyoun Yim, Hwan-Sik Hwang, Hoon-Ki Park, Kye-Yeung Park & Miso Park. (2021) Association between Patient Experience and Medication Compliance of Dyslipidemia: Using Korea National Health and Nutrition Examination Survey (2015). Korean Journal of Family Medicine 42:2, pages 116-122.
Crossref
Crossref
Dan V. Blalock, Hayden B. Bosworth, Bryce B. Reeve & Corrine I. Voils. (2018) Co-occurring reasons for medication nonadherence within subgroups of patients with hyperlipidemia. Journal of Behavioral Medicine 42:2, pages 291-299.
Crossref
Crossref
Hye-Yun Kim, Seung Hyun Lee, Jae-Hyeok Heo, Min-Ky Kim & Tai Hwan Park. (2018) Effect of Statin Withdrawal on Carotid Arterial Distensibility. Journal of Neurosonology and Neuroimaging 10:2, pages 108-114.
Crossref
Crossref
William King, Arron Lacey, James White, Daniel Farewell, Frank Dunstan & David Fone. (2018) Socioeconomic inequality in medication persistence in primary and secondary prevention of coronary heart disease – A population-wide electronic cohort study. PLOS ONE 13:3, pages e0194081.
Crossref
Crossref
Wylie C Hembree, Peggy T Cohen-Kettenis, Louis Gooren, Sabine E Hannema, Walter J Meyer, M Hassan Murad, Stephen M Rosenthal, Joshua D Safer, Vin Tangpricha & Guy G T’Sjoen. (2017) Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism 102:11, pages 3869-3903.
Crossref
Crossref
Enrico Agabiti Rosei & Massimo Salvetti. (2016) Management of Hypercholesterolemia, Appropriateness of Therapeutic Approaches and New Drugs in Patients with High Cardiovascular Risk. High Blood Pressure & Cardiovascular Prevention 23:3, pages 217-230.
Crossref
Crossref
Dimitrios Alexopoulos, Maria Anastasiou-Nana, Moses S. Elisaf, Evangelos Liberopoulos, Loukianos S. Rallidis, Constantinos H. Davos, Alexandros Moulis, Nikos Nikas, Evangelos Zacharis & Panos Vardas. (2016) A contemporary cross-sectional study on dyslipidemia management, cardiovascular risk status, and patients' quality of life in Greece: The CHALLENGE study. International Journal of Cardiology 217, pages 183-189.
Crossref
Crossref
Chern-En Chiang, Jean Ferrières, Nina N Gotcheva, Frederick J Raal, Abdulla Shehab, Jidong Sung, Karin M Henriksson & Michel P Hermans. (2016) Suboptimal Control of Lipid Levels: Results from 29 Countries Participating in the Centralized Pan-Regional Surveys on the Undertreatment of Hypercholesterolaemia (CEPHEUS). Journal of Atherosclerosis and Thrombosis 23:5, pages 567-587.
Crossref
Crossref
Eun Jung Cho & Kyoung Ja Moon. (2015) Related factors of medication adherence in patients with dyslipidemia: The 2010-2012 Korean National Health and Nutrition Examination Survey. Korean Journal of Health Education and Promotion 32:2, pages 65-74.
Crossref
Crossref
Fotios Barkas, Evangelos N. Liberopoulos, Michael S. Kostapanos, George Liamis, Dimitrios Tziallas & Moses Elisaf. (2014) Lipid Target Achievement Among Patients With Very High and High Cardiovascular Risk in a Lipid Clinic. Angiology 66:4, pages 346-353.
Crossref
Crossref
Eunmi Ahn, Dong Wook Shin, Hyung-kook Yang, Jae Moon YunSo Hyun Chun, Beomseok Suh, Hyejin Lee, Ki Young Son & BeLong Cho. (2015) Treatment Gap in the National Health-screening Program in Korea: Claim-based Follow-up of Statin Use for Sustained Hypercholesterolemia. Journal of Korean Medical Science 30:9, pages 1266.
Crossref
Crossref
Mary A. De Vera, Vidula Bhole, Lindsay C. Burns & Diane Lacaille. (2014) Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review. British Journal of Clinical Pharmacology 78:4, pages 684-698.
Crossref
Crossref
Niki Katsiki, Dimitri P. Mikhailidis & Devaki R. Nair. (2014) The effects of antiepileptic drugs on vascular risk factors: A narrative review. Seizure 23:9, pages 677-684.
Crossref
Crossref
Karin Martin-Latry, Julie Cazaux, Marianne Lafitte & Thierry Couffinhal. (2014) Negative impact of physician prescribed drug dosing schedule requirements on patient adherence to cardiovascular drugs. Pharmacoepidemiology and Drug Safety 23:10, pages 1088-1092.
Crossref
Crossref
Eveliina Upmeier, Maarit Jaana Korhonen, Maria Rikala, Arja Helin-Salmivaara & Risto Huupponen. (2014) Older Statin Initiators in Finland—Cardiovascular Risk Profiles and Persistence of Use. Cardiovascular Drugs and Therapy 28:3, pages 263-272.
Crossref
Crossref
Sandra McKellar & Paul Fulbrook. (2014) Compliance with lipid-lowering medication after diagnosis of coronary heart disease. British Journal of Cardiac Nursing 9:5, pages 244-249.
Crossref
Crossref
Natarajan Harivenkatesh, Darling Chellathai David, Natarajan Haribalaji & Muthiah Kothandaramanujam Sudhakar. (2014) Efficacy and Safety of Alternate Day Therapy With Atorvastatin and Fenofibrate Combination in Mixed Dyslipidemia. Journal of Cardiovascular Pharmacology and Therapeutics 19:3, pages 296-303.
Crossref
Crossref
M.H.D. Wasem Alsabbagh, Mark Lemstra, Dean Eurich, Lisa M. Lix, Thomas W. Wilson, Erin Watson & David F. Blackburn. (2014) Socioeconomic Status and Nonadherence to Antihypertensive Drugs: A Systematic Review and Meta-Analysis. Value in Health 17:2, pages 288-296.
Crossref
Crossref
Sahar A. Elgammal, Wafaa T. El-Sherif, Madleen A. Abdou, Ola A. Afifi, Ebtesam F. Alkorn, Sherif H. Galal, Taghreed M. Kamal, Ghada M. Saied & Hamed A. Soliman. (2012) Different patterns of fibrinolytic abnormalities and lipid profile in hypothyroid and hyperthyroid patients. Comparative Clinical Pathology 23:2, pages 407-413.
Crossref
Crossref
Michael S Kostapanos, Dimitri P Mikhailidis & Moses S Elisaf. (2012) Adding ezetimibe to statin treatment: is LDL-C lowering the only benefit?. Future Cardiology 8:6, pages 813-817.
Crossref
Crossref
Derjung M Tarn, Debora A Paterniti, Neil S Wenger, Bradley R Williams & Betty A Chewning. (2012) Older patient, physician and pharmacist perspectives about community pharmacists' roles. International Journal of Pharmacy Practice 20:5, pages 285-293.
Crossref
Crossref
Derjung M. Tarn, Thomas J. Mattimore, Douglas S. Bell, Richard L. Kravitz & Neil S. Wenger. (2012) Provider Views About Responsibility for Medication Adherence and Content of Physician–Older Patient Discussions. Journal of the American Geriatrics Society 60:6, pages 1019-1026.
Crossref
Crossref
Hein A. van Onzenoort, Cees Neef, Willem W. Verberk, H. Peter van Iperen, Peter W. de Leeuw & Paul-Hugo M. van der Kuy. (2012) Determining the feasibility of objective adherence measurement with blister packaging smart technology. American Journal of Health-System Pharmacy 69:10, pages 872-879.
Crossref
Crossref
Caroline HPA Van de Steeg-van Gompel, Michel Wensing & Peter AGM De Smet. (2011) Implementation of patient education at first and second dispensing of statins in Dutch community pharmacies: the sequel of a cluster randomized trial. BMC Health Services Research 11:1.
Crossref
Crossref
Simone RBM Eussen, Nynke de Jong, Cathy JM Rompelberg, Johan Garssen, WM Monique Verschuren & Olaf H Klungel. (2011) Dose-dependent cholesterol-lowering effects of phytosterol/phytostanol-enriched margarine in statin users and statin non-users under free-living conditions. Public Health Nutrition 14:10, pages 1823-1832.
Crossref
Crossref
Giovanni Corrao, Lorenza Scotti, Antonella Zambon, Gianluca Baio, Federica Nicotra, Valentino Conti, Stefano Capri, Elena Tragni, Luca Merlino, Alberico L. Catapano & Giuseppe Mancia. (2011) Cost-effectiveness of enhancing adherence to therapy with statins in the setting of primary cardiovascular prevention. Evidence from an empirical approach based on administrative databases. Atherosclerosis 217:2, pages 479-485.
Crossref
Crossref
Simone R. B. M. Eussen, Marcel L. Bouvy, Cathy J. M. Rompelberg, Menno E. van der Elst, Johan Garssen, Marco H. Oosterveld, Anthonius de Boer, Johan J. de Gier, Henk J. van Kranen & Olaf H. Klungel. (2011) Influence of the use of functional foods enriched with phytosterols/‐stanols on adherence to statin therapy. Pharmacoepidemiology and Drug Safety 20:8, pages 830-837.
Crossref
Crossref
Neil A Smart, Belinda J Marshall, Maxine Daley, Elie Boulos, Janelle Windus, Nadine Baker & Nigel Kwok. (2011) Low-fat diets for acquired hypercholesterolaemia. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Jennifer L. St Sauver, Steven J. Jacobsen, Debra J. Jacobson, Michaela E. McGree, Cynthia J. Girman, Ajay Nehra, Veronique L. Roger & Michael M. Lieber. (2010) Statin use and decreased risk of benign prostatic enlargement and lower urinary tract symptoms. BJU International 107:3, pages 443-450.
Crossref
Crossref
Richard H Chapman, Jason Yeaw & Craig S Roberts. (2010) Association between adherence to calcium-channel blocker and statin medications and likelihood of cardiovascular events among US managed care enrollees. BMC Cardiovascular Disorders 10:1.
Crossref
Crossref
Rodney H. Breau, R. Jeffrey Karnes, Debra J. Jacobson, Michaela E. McGree, Steven J. Jacobsen, Ajay Nehra, Michael M. Lieber & Jennifer L. St. Sauver. (2010) The Association Between Statin Use and the Diagnosis of Prostate Cancer in a Population Based Cohort. The Journal of Urology 184:2, pages 494-500.
Crossref
Crossref
Moses S. ElisafNikos Nikas. (2010) Centralized Pan-European Survey on the Undertreatment of Hypercholesterolemia in Patients Using Lipid Lowering Drugs–The CEPHEUS-Greece Survey. Angiology 61:5, pages 465-474.
Crossref
Crossref
Theodosios Bisdas, Kosmas I. ParaskevasMaximilian Pichlmaier, Matthias Wilhelmi, Axel Haverich & Omke Enno Teebken. (2010) Dorsal (Posterior) Versus Medial Approach for the Surgical Repair of Popliteal Artery Aneurysms. Angiology 61:3, pages 248-252.
Crossref
Crossref
Giovanni Corrao, Valentino Conti, Luca Merlino, Alberico L. Catapano & Giuseppe Mancia. (2010) Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy. Clinical Therapeutics 32:2, pages 300-310.
Crossref
Crossref
Victor Serebruany, Ganesh Cherala, Craig Williams, Serge Surigin, Christopher Booze, Wiktor Kuliczkowski & Dan Atar. (2009) Association of platelet responsiveness with clopidogrel metabolism: Role of compliance in the assessment of “resistance”. American Heart Journal 158:6, pages 925-932.
Crossref
Crossref
Colleen A. McHorney, C. Victor Spain, Charles M. Alexander & Jeffrey Simmons. (2009) Validity of the adherence estimator in the prediction of 9-month persistence with medications prescribed for chronic diseases: A prospective analysis of data from pharmacy claims. Clinical Therapeutics 31:11, pages 2584-2607.
Crossref
Crossref
Dean Ornish. (2009) Mostly Plants. The American Journal of Cardiology 104:7, pages 957-958.
Crossref
Crossref
Wylie C. Hembree, Peggy Cohen-Kettenis, Henriette A. Delemarre-van de Waal, Louis J. Gooren, Walter J. MeyerIIIIII, Norman P. Spack, Vin Tangpricha & Victor M. Montori. (2009) Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism 94:9, pages 3132-3154.
Crossref
Crossref
Neil A Smart, Belinda J Marshall, Maxine Daley, Cassandra Ebenstreit, Elie Boulos & Loren Macaulay. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.